SCHEMBL2912135

SCHEMBL2912135

C[C@@H](O)CNC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.38
GSK3A P49840 3/20 0.38
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
CDK1 P06493 2/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
CCNB2 O95067 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNB3 Q8WWL7 1/20 0.34
P2RX7 Q99572 1/20 0.33
SIRT5 Q9NXA8 2/20 0.32
POLB P06746 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1216751 1.00 GSK3B (0.38) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL12632071 1.00 GSK3B (0.38) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2909835 0.91 GSK3B (0.48) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2912195 0.91 GSK3B (0.48) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2913229 0.90 GSK3B (0.40) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2912584 0.90 GSK3B (0.40) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2904498 0.89 GSK3B (0.47) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2934514 0.89 GSK3B (0.47) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2904193 0.89 SMN1; SMN2 (0.40) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2912251 0.89 SMN1; SMN2 (0.40) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed